Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 33 | $782,785 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
02 Aug 2024 16:05 | CARA | Cara Therapeutics Inc | POSNER CHRISTOPHER | PRESIDENT AND CEO | 01 Aug 2024 | Sale | 4,149 | 0.35 | 1,452 | D |
06 May 2024 16:15 | CARA | Cara Therapeutics Inc | POSNER CHRISTOPHER | PRESIDENT AND CEO | 02 May 2024 | Sale | 3,936 | 0.75 | 2,952 | D |
09 Apr 2024 16:22 | CARA | Cara Therapeutics Inc | GONCALVES JOANA | CHIEF MEDICAL OFFICER | 05 Apr 2024 | Sale | 2,753 | 0.83 | 2,285 | D |
09 Apr 2024 16:21 | CARA | Cara Therapeutics Inc | TERRILLION SCOTT | SEC'Y; CHIEF COMPLIANCE & G.C. | 05 Apr 2024 | Sale | 2,753 | 0.83 | 2,285 | D |
04 Mar 2024 16:24 | CARA | Cara Therapeutics Inc | TERRILLION SCOTT | SEC'Y; CHIEF COMPLIANCE & G.C. | 29 Feb 2024 | Sale | 3,293 | 0.89 | 2,931 | D |
04 Mar 2024 16:19 | CARA | Cara Therapeutics Inc | POSNER CHRISTOPHER | PRESIDENT AND CEO | 29 Feb 2024 | Sale | 5,834 | 0.89 | 5,192 | D |
04 Mar 2024 16:13 | CARA | Cara Therapeutics Inc | GONCALVES JOANA | CHIEF MEDICAL OFFICER | 29 Feb 2024 | Sale | 3,293 | 0.89 | 2,931 | D |
12 Feb 2024 17:16 | CARA | Cara Therapeutics Inc | TERRILLION SCOTT | SEC'Y; CHIEF COMPLIANCE & G.C. | 08 Feb 2023 | Sale | 7,770 | 0.53 | 4,118 | D |
12 Feb 2024 17:15 | CARA | Cara Therapeutics Inc | MAYNARD RYAN D | CHIEF FINANCIAL OFFICER | 08 Feb 2023 | Sale | 5,488 | 0.53 | 2,909 | D |
12 Feb 2024 17:13 | CARA | Cara Therapeutics Inc | GONCALVES JOANA | CHIEF MEDICAL OFFICER | 08 Feb 2023 | Sale | 7,770 | 0.53 | 4,118 | D |
12 Feb 2024 17:10 | CARA | Cara Therapeutics Inc | POSNER CHRISTOPHER | PRESIDENT AND CEO | 08 Feb 2024 | Sale | 35,575 | 0.53 | 18,855 | D |
05 Feb 2024 16:26 | CARA | Cara Therapeutics Inc | POSNER CHRISTOPHER | PRESIDENT AND CEO | 01 Feb 2024 | Sale | 4,981 | 0.55 | 2,740 | D |
03 Nov 2023 16:37 | CARA | Cara Therapeutics Inc | POSNER CHRISTOPHER | President and CEO | 02 Nov 2023 | Sale | 3,796 | 1.22 | 4,631 | D |
04 Aug 2023 17:21 | CARA | Cara Therapeutics Inc | POSNER CHRISTOPHER | President and CEO | 03 Aug 2023 | Sale | 4,307 | 3.07 | 13,222 | D |
27 Jun 2023 16:09 | CARA | Cara Therapeutics Inc | TERRILLION SCOTT | Sec'y; Chief Compliance & G.C. | 23 Jun 2023 | Sale | 2,483 | 3.51 | 8,715 | D |
27 Jun 2023 16:08 | CARA | Cara Therapeutics Inc | MENZAGHI FREDERIQUE PH.D. | Chief Scientific Off,SVP-R&D | 23 Jun 2023 | Sale | 2,993 | 3.51 | 10,505 | D |
27 Jun 2023 16:07 | CARA | Cara Therapeutics Inc | GONCALVES JOANA | Chief Medical Officer | 23 Jun 2023 | Sale | 2,723 | 3.51 | 9,558 | D |
09 May 2023 16:22 | CARA | Cara Therapeutics Inc | POSNER CHRISTOPHER | President and CEO | 05 May 2023 | Sale | 3,869 | 4.4 | 17,024 | D |
06 Apr 2023 17:14 | CARA | Cara Therapeutics Inc | TERRILLION SCOTT | Sec'y; Chief Compliance & G.C. | 04 Apr 2023 | Sale | 2,481 | 4.91 | 12,182 | D |
06 Apr 2023 17:13 | CARA | Cara Therapeutics Inc | GONCALVES JOANA | Chief Medical Officer | 04 Apr 2023 | Sale | 2,481 | 4.91 | 12,182 | D |
06 Apr 2023 17:12 | CARA | Cara Therapeutics Inc | MENZAGHI FREDERIQUE PH.D. | Chief Scientific Off,SVP-R&D | 04 Apr 2023 | Sale | 2,733 | 4.91 | 13,419 | D |
07 Mar 2023 16:47 | CARA | Cara Therapeutics Inc | POSNER CHRISTOPHER | President and CEO | 03 Mar 2023 | Sale | 5,987 | 9.71 | 58,134 | D |
07 Mar 2023 16:46 | CARA | Cara Therapeutics Inc | MENZAGHI FREDERIQUE PH.D. | Chief Scientific Off,SVP-R&D | 03 Mar 2023 | Sale | 6,802 | 9.71 | 66,047 | D |
07 Mar 2023 16:44 | CARA | Cara Therapeutics Inc | TERRILLION SCOTT | Sec'y; Chief Compliance & G.C. | 03 Mar 2023 | Sale | 6,256 | 9.71 | 60,746 | D |
07 Mar 2023 16:43 | CARA | Cara Therapeutics Inc | GONCALVES JOANA | Chief Medical Officer | 03 Mar 2023 | Sale | 6,221 | 9.71 | 60,406 | D |
17 Feb 2023 16:27 | CARA | Cara Therapeutics Inc | GONCALVES JOANA | Chief Medical Officer | 16 Feb 2023 | Sale | 2,265 | 10.2 | 23,103 | D |
03 Feb 2023 18:38 | CARA | Cara Therapeutics Inc | POSNER CHRISTOPHER | President and CEO | 02 Feb 2023 | Sale | 4,191 | 11.8 | 49,454 | D |
19 Jan 2023 16:18 | CARA | Cara Therapeutics Inc | GONCALVES JOANA | Chief Medical Officer | 17 Jan 2023 | Sale | 2,265 | 10.81 | 24,485 | D |
03 Jan 2023 16:32 | CARA | Cara Therapeutics Inc | GONCALVES JOANA | Chief Medical Officer | 29 Dec 2022 | Sale | 2,265 | 10.18 | 23,058 | D |
23 Dec 2022 16:54 | CARA | Cara Therapeutics Inc | MENZAGHI FREDERIQUE PH.D. | Chief Scientific Off,SVP-R&D | 21 Dec 2022 | Sale | 3,506 | 11.27 | 39,513 | D |
23 Dec 2022 16:53 | CARA | Cara Therapeutics Inc | GONCALVES JOANA | Chief Medical Officer | 21 Dec 2022 | Sale | 2,992 | 11.27 | 33,720 | D |
23 Dec 2022 16:52 | CARA | Cara Therapeutics Inc | TERRILLION SCOTT | Sec'y; Chief Compliance & G.C. | 21 Dec 2022 | Sale | 2,561 | 11.27 | 28,862 | D |
18 Nov 2022 17:23 | CARA | Cara Therapeutics Inc | POSNER CHRISTOPHER | President and CEO | 16 Nov 2022 | Sale | 14,470 | 11.13 | 161,051 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)